Harrow (HROW) Revenue (2013 - 2026)
Harrow (HROW) posted Revenue of $70.7 million for Q2 2026, up 59.86% on a QoQ basis from $44.2 million in Q1 2026, and up 10.85% year-over-year from $63.7 million in Q2 2025.
Analysis
Harrow (HROW) Revenue (2013 - 2026) Analysis & Trends
Harrow has reported Revenue for 14 years, with the latest figure at $70.7 million in Q2 2026.
- On a quarterly basis, Revenue rose 10.85% year-over-year to $70.7 million in Q2 2026; TTM through Jun 2026 was $275.6 million, a 21.05% increase from a year earlier, with the FY2025 full-year figure at $272.3 million, up 36.41% from the prior year.
- Revenue was $70.7 million for Q2 2026 at Harrow, up from $44.2 million in the prior quarter.
- The five-year high for Revenue was $89.1 million in Q4 2025, with the low at $20.3 million in Q4 2022.
- Average Revenue over 5 years is $44.8 million, with a median of $40.3 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Revenue jumped 83.83% in 2024, then decreased 7.59% in 2026.
- Over 5 years, Revenue stood at $20.3 million in 2022, then jumped by 78.83% to $36.4 million in 2023, then surged by 83.83% to $66.8 million in 2024, then jumped by 33.31% to $89.1 million in 2025, then slipped by 20.69% to $70.7 million in 2026.
- The last three Revenue figures came in at $70.7 million (Q2 2026), $44.2 million (Q1 2026), and $89.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 15.03 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 13.48 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | - |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 1.67 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 783.30 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | 70.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.66 Mn |
| Mar 31, 2026 | 44.20 Mn |
| Dec 31, 2025 | 89.09 Mn |
| Sep 30, 2025 | 71.64 Mn |
| Jun 30, 2025 | 63.74 Mn |
| Mar 31, 2025 | 47.83 Mn |
| Dec 31, 2024 | 66.83 Mn |
| Sep 30, 2024 | 49.26 Mn |
| Jun 30, 2024 | 48.94 Mn |
| Mar 31, 2024 | 34.59 Mn |
| Dec 31, 2023 | 36.36 Mn |
| Sep 30, 2023 | 34.27 Mn |
| Jun 30, 2023 | 33.47 Mn |
| Mar 31, 2023 | 26.10 Mn |
| Dec 31, 2022 | 20.33 Mn |
| Sep 30, 2022 | 22.82 Mn |
| Jun 30, 2022 | 23.32 Mn |
| Mar 31, 2022 | 22.12 Mn |
| Dec 31, 2021 | 20.19 Mn |
| Sep 30, 2021 | 18.71 Mn |